Company · CIK 1847903
Centessa Pharmaceuticals plc
| CIK | 1847903 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | X0 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-08-16 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-282032 | 2024-09-11 | 2025-11-24 | 6 | |
| 333-265978 | 2022-07-01 | 2024-04-25 | 5 | |
| 333-255393 | 2021-04-21 | 2021-06-01 | 6 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-11-24 | 424B5Shelf takedown | 333-282032 | 0001193125-25-292008 |
| 2025-11-13 | 424B5Shelf takedown | 333-282032 | 0001193125-25-278668 |
| 2025-11-12 | 424B5Shelf takedown | 333-282032 | 0001193125-25-275608 |
| 2024-09-13 | 424B5Shelf takedown | 333-282032 | 0001193125-24-218834 |
| 2024-09-11 | 424B5Shelf takedown | 333-282032 | 0001193125-24-217290 |
| 2024-09-11 | S-3ASRShelf registered | 333-282032 | 0001193125-24-217225 |
| 2024-04-25 | 424B5Shelf takedown | 333-265978 | 0001193125-24-110975 |
| 2024-04-23 | 424B5Shelf takedown | 333-265978 | 0001193125-24-107219 |
| 2023-01-27 | 424B5Shelf takedown | 333-265978 | 0001193125-23-017733 |
| 2022-07-12 | EFFECTDeclared effective | 333-265978 | 9999999995-22-002042 |
| 2022-07-01 | S-3Shelf registered | 333-265978 | 0001193125-22-187189 |
| 2021-06-01 | 424B4Final prospectus | 333-255393 | 0001193125-21-178516 |
| 2021-05-27 | EFFECTDeclared effective | 333-256385 | 9999999995-21-002148 |
| 2021-05-27 | EFFECTDeclared effective | 333-255393 | 9999999995-21-002143 |
| 2021-05-26 | S-1/AAmendment | 333-255393 | 0001193125-21-173367 |
| 2021-05-24 | S-1/AAmendment | 333-255393 | 0001193125-21-170068 |
| 2021-05-12 | S-1/AAmendment | 333-255393 | 0001193125-21-159305 |
| 2021-04-21 | S-1Registration filed | 333-255393 | 0001193125-21-123969 |
| 2021-03-15 | DRSDraft made public | 377-04416 | 0000950123-21-003466 |